{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 16539, "pageSize": 18, "pageCount": 17777, "rows": [ { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "appendix_data", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/29", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/30", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-30", "loopMatches": [ { "to": 31, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "73d97d04-557b-44ca-a1d1-9e0d6b27f716", "evidence": "Slides 30-31 summarize APX3330's benefits and key takeaways", "position": 1, "objective": "Why APX3330 is a good solution?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/31", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-31", "loopMatches": [ { "to": 31, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "73d97d04-557b-44ca-a1d1-9e0d6b27f716", "evidence": "Slides 30-31 summarize APX3330's benefits and key takeaways", "position": 1, "objective": "Why APX3330 is a good solution?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/32", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/33", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "product_demo", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/34", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "appendix_data", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/35", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/36", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "preclinical_data", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/37", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-37", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/38", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-38", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/39", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-39", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "competitive_analysis", "function": "compare_peers", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/40", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-40", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "team_bio", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/41", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-41", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-75a1-7387-968b-d0dc513bf421", "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d", "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides", "authorId": "ocuphire-pharma", "authorName": "Ocuphire Pharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "team_bio", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/42", "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421", "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-42", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 29, "beatId": "691510f1-c63c-46db-bda1-6d94434f6f9b", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Slides 29-42 discuss key takeaways, corporate highlights, and future plans", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-7622-7276-809b-6a87e5d3f4e1", "docSlug": "88ead81802f558347ce0f4a5f66b2292", "documentTitle": "Office Properties Income Trust | Investor Presentation Deck | 25 slides", "authorId": "office-properties-income-trust", "authorName": "Office Properties Income Trust", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/MM_AzA3OEZmHyFMYGvS9ReOTtQryHFEQYXRCvRLzsz4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84OGVhZDgxODAyZjU1ODM0N2NlMGY0YTVmNjZiMjI5Mi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-7622-7276-809b-6a87e5d3f4e1/1", "deckHref": "/decks/019de517-7622-7276-809b-6a87e5d3f4e1", "deckAnchorHref": "/decks/019de517-7622-7276-809b-6a87e5d3f4e1#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/fNB2cdro2XHLmGe3IP104nmiB2CCyvPDIT5yD8gpY8U/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84OGVhZDgxODAyZjU1ODM0N2NlMGY0YTVmNjZiMjI5Mi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/1f7DxeEaPQvZl2W_h8q5LqEiLHhhZ2Mie2y0Ja1ZKvs/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84OGVhZDgxODAyZjU1ODM0N2NlMGY0YTVmNjZiMjI5Mi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/oudgDySl0uXxN3co5MCrFBxLh0a9TsHxG-kIcMgjEDQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84OGVhZDgxODAyZjU1ODM0N2NlMGY0YTVmNjZiMjI5Mi9wMDAxLnBuZw" }, { "docId": "019de517-7622-7276-809b-6a87e5d3f4e1", "docSlug": "88ead81802f558347ce0f4a5f66b2292", "documentTitle": "Office Properties Income Trust | Investor Presentation Deck | 25 slides", "authorId": "office-properties-income-trust", "authorName": "Office Properties Income Trust", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 2, "slideType": "disclaimer", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-7622-7276-809b-6a87e5d3f4e1/2", "deckHref": "/decks/019de517-7622-7276-809b-6a87e5d3f4e1", "deckAnchorHref": "/decks/019de517-7622-7276-809b-6a87e5d3f4e1#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-7622-7276-809b-6a87e5d3f4e1", "docSlug": "88ead81802f558347ce0f4a5f66b2292", "documentTitle": "Office Properties Income Trust | Investor Presentation Deck | 25 slides", "authorId": "office-properties-income-trust", "authorName": "Office Properties Income Trust", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-7622-7276-809b-6a87e5d3f4e1/3", "deckHref": "/decks/019de517-7622-7276-809b-6a87e5d3f4e1", "deckAnchorHref": "/decks/019de517-7622-7276-809b-6a87e5d3f4e1#slide-3", "loopMatches": [ { "to": 4, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "915d6ac6-5fce-4676-b241-8ab6fc0f3464", "evidence": "The presentation starts with an overview of OPI and its goals", "position": 1, "objective": "Explain OPI's strategy and goals", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 4, "from": 3, "beatId": "35648600-8ccb-4cec-8ef6-08565020e44f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The presentation starts with an overview of OPI and recent company highlights", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de517-7622-7276-809b-6a87e5d3f4e1", "docSlug": "88ead81802f558347ce0f4a5f66b2292", "documentTitle": "Office Properties Income Trust | Investor Presentation Deck | 25 slides", "authorId": "office-properties-income-trust", "authorName": "Office Properties Income Trust", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 4, "slideType": "other", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de517-7622-7276-809b-6a87e5d3f4e1/4", "deckHref": "/decks/019de517-7622-7276-809b-6a87e5d3f4e1", "deckAnchorHref": "/decks/019de517-7622-7276-809b-6a87e5d3f4e1#slide-4", "loopMatches": [ { "to": 4, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "915d6ac6-5fce-4676-b241-8ab6fc0f3464", "evidence": "The presentation starts with an overview of OPI and its goals", "position": 1, "objective": "Explain OPI's strategy and goals", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 4, "from": 3, "beatId": "35648600-8ccb-4cec-8ef6-08565020e44f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The presentation starts with an overview of OPI and recent company highlights", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }